Research Article

A Type II Arabinogalactan from Anoectochilus formosanus for G-CSF Production in Macrophages and Leukopenia Improvement in CT26-Bearing Mice Treated with 5-Fluorouracil

Figure 7

Effects of AGAF administration on CT26-colon-carcinoma-bearing mice. Mice were orally administrated with H2O or AGAF (15 and 45 mg/kg) every day. 5-FU treatment on mice was with 25 mg/kg i.p. every other day. Mice in control group were not inoculated with CT26. (a) The growth of tumor sizes in mice inoculated s.c. with CT26 (1 106 cell/mouse) on Day 0. The tumor sizes were scored every three days since Day 7. (b) The final body-weight of CT26 bearing mice and control mice. (c) The spleen weight of CT26-bearing mice and control mice. (d) The tumor weight of CT26-bearing mice and control mice. (e) The number of WBC in CT26-bearing mice and control mice. The blood was analyzed under complete blood count test. The values are presented as the mean SD; . Different superscript letters denote significant differences across group as analyzed by Duncan’s multiple test ( ).
458075.fig.007a
(a)
458075.fig.007b
(b)
458075.fig.007c
(c)
458075.fig.007d
(d)
458075.fig.007e
(e)